Treatment.com AI Stock Price, News & Analysis

Rocket Doctor AI (CSE: AIDR) has expanded its pharmacy-based virtual care program to 50 independent pharmacies across Canada. The program integrates physician-led, AI-powered virtual care directly into pharmacies, particularly in rural and underserved areas.

The platform has facilitated over 16,500 appointments, with 75% resulting in prescriptions, of which 99% were filled at the originating pharmacy. The service includes urgent care, family medicine, and specialist services covered by provincial insurance. In Stony Plain, Alberta, one pharmacy completed 530 appointments, resulting in 424 prescriptions.

The company has also expanded to the United States, implementing virtual health kiosks in 3 housing complexes in inner-city New York, with plans to partner with Federally Qualified Health Centers (FQHCs).

Rocket Doctor AI (CSE: AIDR, OTC: AIRDF) announced that its digital health platform is now in-network with Aetna in New York State for both Medicare and commercial insurance plans. This credentialing enables Aetna's members to access Rocket Doctor's virtual healthcare services with reduced out-of-pocket costs.

The company's platform offers urgent care, chronic disease management, preventive and mental health services. Rocket Doctor is already operating in New York through partnerships with EngageWell IPA and the CVS Health Foundation's Healthy Aging Program, which received $1 million in funding to provide free virtual health screenings for adults over 60.

Additionally, the company granted 64,896 RSUs and 16,224 stock options to a consultant, with options exercisable at C$0.67 per share over a three-year period.

Rocket Doctor AI (OTC:TREIF) reported its first revenue-generating quarter with Q2 2025 revenue of $0.5M following the strategic acquisition of Rocket Doctor Inc. The company achieved an 89% gross margin but posted a net loss of $2.7M ($0.04 per share).

Key developments include the integration of Rocket Doctor's platform supporting 300+ clinicians and 600,000+ patient visits, a partnership with Central California Alliance for Health serving ~450,000 Medi-Cal members, and successful deployment of their Medical Education Suite to 240 University of Minnesota medical students. The company has shifted from B2C to B2B model, focusing on AI-driven healthcare solutions powered by their Global Library of Medicine (GLM) technology.

Rocket Doctor AI Inc. (CSE: AIDR; OTC: TREIF) has successfully closed an over-subscribed non-brokered private placement, raising total gross proceeds of C$4.23 million. The offering consisted of 3,677,400 special warrants at $0.50 per warrant for C$1.84 million, and 4,792,000 units at $0.50 per unit for C$2.39 million.

Each unit includes one common share and one purchase warrant exercisable at $0.75 for 12 months. The company paid C$201,616 in finder's fees and issued 403,232 broker warrants. The funds will be used for sales and administrative expenses, software R&D, and working capital, with a focus on accelerating US expansion plans.

Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) has announced its rebranding to Rocket Doctor AI Inc., with trading under the new ticker symbol AIDR beginning August 21, 2025. This strategic transformation follows the successful April 2025 acquisition of Rocket Doctor Inc.

The rebranding unifies the company's proprietary Global Library of Medicine (GLM) with Rocket Doctor's digital health platform, creating an integrated solution that leverages AI, large language models, and connected medical devices to improve healthcare access. The combined technology stack focuses on delivering AI-enhanced clinical and diagnostic tools, particularly targeting rural, remote, and underserved communities across North America.

The company's GLM platform has undergone over 10,000 expert medical reviews and aims to reduce administrative burden for healthcare professionals while improving patient care quality and consistency.

Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) reports significant growth of its Rocket Doctor platform amid Ontario's healthcare crisis. Patient visits through the platform increased 63% year-over-year, from 38,378 in 2023 to 62,648 in 2024. Since 2020, Rocket Doctor has served over 360,000 patients in Ontario.

The platform has been particularly impactful in underserved areas, with 102,000+ patients from communities under 30,000 population accessing care. Physician adoption continues to grow, with 138 Ontario doctors now on the platform, including 27 new physicians joining in the first half of 2025.

This growth comes as Ontario faces its worst year of ER closures in 2024, with 1 in 5 hospitals experiencing unplanned shutdowns, while 2.5 million Ontarians lack a family doctor as of 2023.

Treatment.com AI (CSE: TRUE, OTC: TREIF) has reported significant success with its Rocket Doctor platform's Emergency Department (ED) diversion program. At Georgian Bay General Hospital, the program has successfully managed over 3,065 patients between June 2022 and December 2024, with 97.5% handled virtually and only 1% requiring ED redirection.

The program has generated estimated savings of $1.4 million, based on average ED visit costs of $475. In Alberta, Rocket Doctor has facilitated 12,000+ patient visits in the last three months, achieving a 98% virtual resolution rate with less than 1% requiring ED visits. The platform combines smart triage, provider infrastructure, and AI-enabled care to address Canada's emergency department crisis, particularly impacting rural communities.

Treatment.com AI (OTC: TREIF) has engaged Independent Trading Group (ITG) as its market maker starting July 29, 2025. The agreement aims to maintain reasonable market conditions and enhance the liquidity of Treatment's common shares across all trading venues.

Under the agreement terms, ITG will receive CAD $5,500 monthly compensation, with an initial one-month term that automatically renews unless terminated with 30 days' notice. No performance factors, shares, or options are included in the compensation package. ITG, established in 1992, is a Toronto-based CIRO dealer-member specializing in market making and liquidity provision services.

Treatment.com AI (OTC: TREIF) has announced strategic marketing partnerships with two service providers to enhance its digital presence and investor awareness. The company has engaged 45 Degrees Inc. for a six-month digital marketing campaign at USD $180,000, with potential monthly extensions at $25,000.

Additionally, Treatment.com has partnered with Investment Publishing LLC for a one-year investor relations strategy enhancement program. As compensation, the company has issued 400,000 stock options each to both service providers' principals, exercisable at $0.45 per share for three years. The company has also granted an additional 400,000 options to arm's length consultants under the same terms.